It is with great pleasure that I present the Ontario Genomics Institute's (OGI) fiscal year (FY) 2050 2011 Annual Report.

The past year has been one of monumental change – both within the organization and in the life sciences sector
as a whole.

Ten years on from the sequencing of the human genome, leaps and bounds have been made in discovering how the human body works, how disease develops, how we can diagnose diseases earlier and with less invasive methods,
and how we can design better and safer drugs. Genomics has also greatly aided work in environmental sustainability
and agriculture.

We are now at a point where a genomics approach can be taken to battle almost every challenge we face. Take shortage of food, or oil spills, or border protection and you'll find that genomics researchers are discovering, creating and refining ways to grow draught and flood resistant crops, clear up oil spills like that seen in the Gulf of Mexico and identify invasive species at border crossings, protecting our health, forests and industry.

So much has been achieved in the last 10 years, but the best is yet to come. It is going to be the next few decades that
will really bear the fruit of the genomics research taking place right now.

The sheer power and potential of genomics are almost incomprehensible. The way we receive health care will be revolutionized, and our environment and agricultural industries will see untold and unforeseen benefits.

We are at the cusp of a genomics revolution. I've never been more excited and energized about the life sciences as
I am right now.

I will end with a note of thanks to our board of directors. Thanks to our interim chair, Mark Lievonen, for holding the fort during a transition period at the organization, and thanks to our new chair of the board, Dr. Brian Underdown, who I am very much looking forward to working with.

I would like to extend our appreciation to OGI's previous President and CEO, Dr. Christian Burks. For six years he guided the organization through change and firmly positioned it at the centre of genomics in Ontario. His leadership left me with a solid, dedicated and imaginative organization when I took up the reins as President and CEO in December 2010.

Finally, I would like to extend my appreciation to all the staff at OGI, for without them this organization would not be where it is today and the life sciences sector in Ontario would not be as vibrant as it is.